What is the Beta Drugs Ltd operating profit?

The Beta Drugs Ltd operating profit is ₹30.02 crore for the latest reported period, compared with ₹30.17 crore previously.

What is the Beta Drugs Ltd operating profit margin?

The Beta Drugs Ltd operating profit margin is 13.32% for the latest reported period, indicating the percentage of revenue retained as operating profit.

What is the Beta Drugs Ltd EPS?

The Beta Drugs Ltd earnings per share (EPS) is ₹14.14 for the latest reported period.

What are the Beta Drugs Ltd total assets?

The Beta Drugs Ltd total assets are valued at approximately ₹334.96 crore as of FY26.

What are the Beta Drugs Ltd total liabilities?

The Beta Drugs Ltd total liabilities stand at approximately ₹185.40 crore as of FY26.

What is the Beta Drugs Ltd total debt?

The Beta Drugs Ltd total debt is approximately ₹130.39 crore as of FY26.

What is the Beta Drugs Ltd cash flow from operations?

The Beta Drugs Ltd cash flow from operations was approximately ₹19.20 crore during the latest reported period.

How has the Beta Drugs Ltd revenue changed?

The revenue of Beta Drugs Ltd changed from ₹220.20 crore to ₹225.43 crore, representing a growth of 2.38%.

How has the Beta Drugs Ltd net profit changed?

The net profit of Beta Drugs Ltd changed from ₹15.43 crore to ₹14.33 crore, representing a decline of 7.13%.

Beta Drugs Ltd Financials: Revenue, Profit, Assets, Debt & More

Beta Drugs Ltd Share Price

Detail Overview

Pharmaceuticals - Indian - Bulk DrugsNSE

₹1,894.60

-76.40(-3.88%)

As on 23 Oct 2026 at 15:54

As of 23 Oct 2026 at 15:54, Beta Drugs Ltd is trading at ₹1,894.60. The 52-week range stands at ₹990.10–₹2,807.90, with a market cap of ₹2.10 thousand crore. At a P/E of 115.17 and a dividend yield of 0.00%, it is a small-cap stock in the Pharmaceuticals sector.

Beta Drugs Ltd Financial Statements

*All values are in INR Crore

Frequently asked questions

The Beta Drugs Ltd revenue for the latest reported period is ₹225.43 crore, compared with ₹220.20 crore in the previous period.